View Cart  

Janssen Biotech Gets Form 483 for Microbial Contamination Concerns

A A
Lax investigations into microbial contamination of manufacturing equipment and inadequate controls to minimize such risks have landed Janssen Biotech a Form 483.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00